Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Mar 15;12(3):266.
doi: 10.3390/pharmaceutics12030266.

3D Printing of Pharmaceuticals and Drug Delivery Devices

Essyrose Mathew  1 , Giulia Pitzanti  1   2 , Eneko Larrañeta  1 , Dimitrios A Lamprou  1
Affiliations
Editorial

3D Printing of Pharmaceuticals and Drug Delivery Devices

Essyrose Mathew et al. Pharmaceutics. .

Abstract

The process of 3D printing (3DP) was patented in 1986; however, the research in the field of 3DP did not become popular until the last decade. There has been an increasing research into the areas of 3DP for medical applications for fabricating prosthetics, bioprinting and pharmaceutics. This novel method allows the manufacture of dosage forms on demand, with modifications in the geometry and size resulting in changes to the release and dosage behaviour of the product. 3DP will allow wider adoption of personalised medicine due to the diversity and simplicity to change the design and dosage of the products, allowing the devices to be designed specific to the individual with the ability to alternate the drugs added to the product. Personalisation also has the potential to decrease the common side effects associated with generic dosage forms. This Special Issue Editorial outlines the current innovative research surrounding the topic of 3DP, focusing on bioprinting and various types of 3DP on applications for drug delivery as well advantages and future directions in this field of research.

Keywords: 3D printing; additive manufacturing; bioprinting; computer-aided design (CAD); drug delivery; personalized medicine; pharmaceutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Stewart S.A., Domínguez-Robles J., McIlorum V.J., Mancuso E., Lamprou D.A., Donnelly R.F., Larrañeta E. Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing. Pharmaceutics. 2020;12:105. doi: 10.3390/pharmaceutics12020105. - DOI - PMC - PubMed
    1. Giri B.R., Song E.S., Kwon J., Lee J.-H., Park J.-B., Kim D.W. Fabrication of Intragastric Floating, Controlled Release 3D Printed Theophylline Tablets Using Hot-Melt Extrusion and Fused Deposition Modeling. Pharmaceutics. 2020;12:77. doi: 10.3390/pharmaceutics12010077. - DOI - PMC - PubMed
    1. Lamichhane S., Park J.-B., Sohn D.H., Lee S. Customized Novel Design of 3D Printed Pregabalin Tablets for Intra-Gastric Floating and Controlled Release Using Fused Deposition Modeling. Pharmaceutics. 2019;11:564. doi: 10.3390/pharmaceutics11110564. - DOI - PMC - PubMed
    1. Reddy Dumpa N., Bandari S., A Repka M. Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing. Pharmaceutics. 2020;12:52. doi: 10.3390/pharmaceutics12010052. - DOI - PMC - PubMed
    1. Chew S.L., Modica de Mohac L., Tolulope Raimi-Abraham B. 3D-Printed Solid Dispersion Drug Products. Pharmaceutics. 2019;11:672. doi: 10.3390/pharmaceutics11120672. - DOI - PMC - PubMed

Publication types

LinkOut - more resources